Faeth Therapeutics reported total assets of $145.38M and total liabilities of $9.58M for the quarter ended Jun 2026. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.88M | 1.19M | 1.35M | 1.49M | 1.47M | 1.44M | 1.58M | 1.57M | 1.59M | 1.73M | 1.86M | 2.00M | 2.14M | 1.50M | 0.45M | 0.48M | 0.51M | 0.54M | 0.58M | 0.61M | ||||||
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 9.53M | 7.16M | 8.72M | 9.90M | 11.45M | 17.80M | 8.11M | 10.23M | 11.34M | 13.01M | 10.96M | 11.89M | 19.13M | 9.99M | 9.88M | 12.56M | 10.56M | 8.67M | 152.32M | 26.90M | ||||||
| Prepaid Assets | 1.20M | 0.55M | 2.55M | 3.48M | 1.59M | 1.13M | 2.65M | 1.98M | 1.50M | 1.17M | 1.88M | 1.51M | 1.02M | 0.47M | 0.91M | 0.83M | 0.50M | 0.23M | 0.97M | 1.36M | ||||||
| Current Assets | 158.16M | 148.54M | 138.98M | 127.49M | 118.48M | 108.59M | 98.61M | 81.07M | 73.84M | 67.25M | 60.23M | 53.94M | 48.10M | 41.93M | 35.68M | 29.57M | 25.79M | 21.51M | 204.23M | 188.66M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 3.06M | 4.64M | 2.20M | 2.11M | 2.21M | 2.05M | 1.81M | 1.47M | 1.30M | 1.17M | 1.06M | 1.04M | 0.90M | 0.42M | 0.16M | 0.14M | 0.11M | 0.08M | 0.07M | 0.04M | ||||||
| Other Non-Current Assets | 0.03M | 0.04M | 0.04M | 0.04M | 0.04M | 0.06M | 0.08M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.05M | 0.02M | 0.02M | 0.02M | 0.02M | 0.17M | 0.08M | ||||||
| Non-Current Assets | 3.09M | 4.68M | 11.06M | 10.54M | 10.32M | 9.79M | 9.32M | 8.51M | 7.82M | 7.12M | 6.46M | 5.86M | 5.16M | 3.43M | -35.68M | -29.57M | 1.80M | 1.40M | 1.15M | -43.27M | ||||||
| Assets | 161.25M | 153.22M | 150.04M | 138.04M | 128.80M | 118.38M | 107.93M | 89.58M | 81.66M | 74.37M | 66.69M | 59.80M | 53.25M | 45.36M | 27.59M | 22.90M | 205.38M | 145.38M | ||||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 3.61M | 2.46M | 5.10M | 2.42M | 4.66M | 4.47M | 4.71M | 2.33M | 2.73M | 1.69M | 2.00M | 1.65M | 1.68M | 1.25M | 2.36M | 1.14M | 1.41M | 1.48M | 8.98M | 7.57M | ||||||
| Payables | 3.61M | 2.46M | 5.10M | 2.42M | 4.66M | 4.47M | 4.71M | 2.33M | 2.73M | 1.69M | 2.00M | 1.65M | 1.68M | 1.25M | 2.36M | 1.14M | 1.41M | 1.48M | 8.98M | 7.57M | ||||||
| Accumulated Expenses | 1.61M | 1.75M | 0.56M | 1.02M | 1.76M | 2.46M | 0.58M | 0.71M | 1.09M | 1.51M | 0.51M | 0.85M | 1.33M | 1.88M | 1.91M | 0.78M | 1.16M | 1.32M | 5.43M | 5.25M | ||||||
| Other Accumulated Expenses | 1.65M | 0.22M | 0.13M | 0.07M | 0.08M | 0.08M | 0.08M | 0.14M | 0.17M | |||||||||||||||||
| Current Leases | 0.68M | 1.16M | 1.19M | 1.22M | 1.25M | 1.41M | 1.43M | 1.53M | 1.57M | 1.61M | 1.59M | 1.60M | 1.59M | 1.57M | 1.62M | 1.68M | 1.37M | 1.02M | 0.59M | |||||||
| Total Current Liabilities | 5.26M | 4.89M | 7.61M | 5.43M | 8.49M | 9.07M | 7.58M | 5.36M | 6.23M | 5.64M | 4.99M | 4.95M | 5.44M | 5.45M | 5.23M | 3.87M | 4.44M | 4.25M | 14.19M | 9.58M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Capital Leases | 1.67M | 1.85M | 1.72M | 1.68M | 1.58M | 1.35M | 1.16M | 0.96M | 0.77M | 0.57M | 0.38M | 0.21M | 0.10M | 0.04M | 0.00M | |||||||||||
| Non-Current Debt | ||||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||
| Minority Interest | 328.48M | 6.77M | ||||||||||||||||||||||||
| Operating Leases | 5.28M | 4.97M | 4.64M | 4.32M | 4.12M | 3.79M | 3.40M | 3.00M | 2.59M | 2.21M | 1.83M | 1.43M | 1.02M | 0.59M | 0.15M | 0.06M | ||||||||||
| Other Non-Current Liabilities | 0.78M | 0.15M | 0.03M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.00M | 0.00M | ||||||||||||||||
| Total Non-Current Liabilities | 5.26M | 6.56M | 14.97M | 13.05M | 10.31M | 10.59M | 9.41M | 8.15M | 7.54M | 4.31M | 14.19M | 9.58M | ||||||||||||||
| Total Liabilities | 6.04M | 6.71M | 14.73M | 12.12M | 14.82M | 14.97M | 13.08M | 10.38M | 10.66M | 9.48M | 8.22M | 7.61M | 7.47M | 6.97M | 6.29M | 4.47M | 4.58M | 4.31M | 14.19M | 9.58M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | ||||||||||||||||||||||||||
| Common Equity | 155.21M | 146.51M | 135.31M | 125.92M | 113.99M | 103.41M | 94.85M | 79.20M | 71.00M | 64.89M | 58.47M | 52.19M | 45.78M | 38.39M | 31.99M | 27.31M | 23.01M | 18.59M | -137.29M | 172.96M | ||||||
| Liabilities and Shareholders Equity | 161.25M | 153.22M | 150.04M | 138.04M | 128.80M | 118.38M | 107.93M | 89.58M | 81.66M | 74.37M | 66.69M | 59.80M | 53.25M | 45.36M | 27.59M | 22.90M | 205.38M | 145.38M | ||||||||
| Retained Earnings | -139.84M | -149.21M | -161.61M | -172.15M | -185.60M | -197.79M | -208.00M | -217.40M | -224.50M | -231.90M | -239.90M | -247.03M | -254.30M | -262.05M | -268.92M | -273.90M | -278.42M | -283.14M | -453.40M | -469.40M | ||||||
| Treasury Shares | 0.02M | 502.00 |